GB2349877A - Preparing carbonated hydroxyapatite - Google Patents

Preparing carbonated hydroxyapatite Download PDF

Info

Publication number
GB2349877A
GB2349877A GB9910847A GB9910847A GB2349877A GB 2349877 A GB2349877 A GB 2349877A GB 9910847 A GB9910847 A GB 9910847A GB 9910847 A GB9910847 A GB 9910847A GB 2349877 A GB2349877 A GB 2349877A
Authority
GB
United Kingdom
Prior art keywords
hydroxyapatite
carbonate
heating
atmosphere
molar ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9910847A
Other versions
GB9910847D0 (en
Inventor
Iain Ronald Gibson
William Bonfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abonetics Ltd
Original Assignee
Abonetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abonetics Ltd filed Critical Abonetics Ltd
Priority to GB9910847A priority Critical patent/GB2349877A/en
Publication of GB9910847D0 publication Critical patent/GB9910847D0/en
Priority to AU45921/00A priority patent/AU4592100A/en
Priority to PCT/GB2000/001738 priority patent/WO2000068144A1/en
Publication of GB2349877A publication Critical patent/GB2349877A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A process for the preparation of a carbonate-substituted hydroxyapatite comprising heating an hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 at 600 to 1200{C in a atmosphere comprising CO<SB>2</SB>, and optionally H<SB>2</SB>O. This process enables a substantially single phase carbonate-substituted hydroxyapatite composition to be produced which does not contain sodium or ammonium ions.

Description

1 2349877 METHOD FOR THE PREPARATION OF CARB(MATED HYDROXYAPATITE
COMPOSITIONS The present invention relates to a method for forming carbonated hydroxyapatite compositions and, in particular, to a method for forming carbonated hydroxyapatite compositions which are substantially sodium-free and ammonium-free and which are substantially of a single phase.
Synthetic hydroxyapatite Cajo (P04) 6 (OH) 2 has been reported as having been used as a bone replacement material in porous, granular, plasma sprayed and dense forms. Investigations have shown hydroxyapatite to be similar structurally to bone.material. However hydroxyapatite is one of the range of stoichiometric calcium phosphate apatites. Human and animal bone mineral have been shown to contain significant amounts of from 3 to 7 wt% of carbonate. There is evidence that the carbonate group can substitute in two sites, the phosphate and hydroxyl sites, termed B and A respectively; bone mineral being predominately a B type apatite. As a result of this similarity in chemical composition, it is envisaged that carbonated hydroxyapatite will have better bioactivity than unsubstituted stoichiometric hydroxyapatite which is currently used in commercial applications, such as plasma-sprayed coatings on metallic implants and porous hydroxyapatite ceramic bone substitutes. A carbonate substituted hydroxyapatite would also find application for use in chromatography and for purification, such as the removal of heavy metal ions by adsorption.
The preparation of carbonate-substituted hydroxyapatite ceramic materials must be easy and reproducible in order to achieve commercial exploitation. Additionally, the carbonate-substituted hydroxyapatite composition must be thermally stable such that it will not decompose to undesirable secondary phases (e.g. tricalcium. phosphate or calcium oxide) upon calcining/sintering. Furthermore, during this heat treatment, the carbonate-substituted hydroxyapatite must not lose the carbonate ions that have been substituted into the hydroxyapatite structure.
Up to the present time, the methods which have been reported to prepare carbonate-substituted hydroxyapatite compositions have involved one of the following procedures.
The heating of a stoichiometric hydroxyapatite ceramic composition in a C02 atmosphere at approximately 9000C for several days (R.Wallaeys, Silicon, Sulphur, Phosphates. Coll. Int. Union Pure Appl. Chem. MUnster (1954) 183-1901. This process results in low levels of carbonate substitution, with poor control over the extent of carbonate substitution and the homogeneity of the substitution throughout the sample. Furthermore, the carbonate substitution is at the wrong site, i.e. the A site, to provide a material which is equivalent to bone.
A wet precipitation method using Na2CO3, NaHC03 or (NH4)2CO3 as a source of carbonate ions [See, for example: Y. Doi, Y. Moriwaki, T. Aoba, M. Okazati, J.
Takahashi and K. Joshin, "Carbonate apatites from aqueous and non-aqueous media studied by esr, IR and X-Ray Diffraction: Effect of NH4+ ions on crystallographic parameters", J. Deut. Res. 61(1982) 429-434, D.G.A. Nelson and J.D.B. Featherstone, "Preparation analysis and characterization of Carbonated apatites", Calcif. Tiss. Int. 34(1082) 569 581]. This process results in the substitution of the additional ions, Na+ or NH4+, into the hydroxyapatite structure, poor thermal stability of the product upon calcining/sintering, the loss of large quantities of the carbonate ions upon heating, and poor control of the levels of the carbonate substitution.
Incorporation of carbonate ions by soaking carbonate-free samples in a saturated solution of carbon-dioxide. [E.G. Nordstr6m and K.H. Karlsson, "Carbonate-doped hydroxyapatite", J.Mat. Sci. Mater. Med. 1 (1990) 1821841. A soaking time of 2 months gives a carbonate content of 4 to 5.5 wt% as determined by TGA. At 11000C a 3.3wt% C02 loss was registered. This method involves soaking pure, stoichiometric, sintered hydroxyapatite ceramic powder in mineral water for up to 2 months to try to lionexchange' carbonate ions from solution into the hydroxyapatite ceramic.
Sintering of stoichiometric hydroxyapatite in a C02atmosphere for several days to give A-type substitution. Co- precipitating some carbonate and some calcium phosphate to give B-type substitution. Reacting fluorapatite and alkaline earth carbonate at 900C in dry carbon dioxide gas to give B-type substitution [all described in G. Bonel, "Contribution a 1'6tude de la carbonation des apatites", Ann. Chim. 7 (1972) 127-1441.
Slowly adding a solution of calcium nitrate in contact with carbon dioxide gas to a solution of ammonium phosphate (pH=8.6,80'C). The precipitation lasts 64 hours and the suspension is maintained at the above conditions for a further 51 hours [A. Barroug, C. Rey, J.C. Trombe and G. Montel, "The synthesis in aqueous-media of AB carbonate apatite similar to dental enamel", C.R.Acad. Sc. Paris 292[3] (1981) 303 3061. After ageing for 51 hours the apatite contains 1.3 wt% carbonate. Chemical analysis gives a Ca/P ratio of 1.63-1.61. No heat treatment is carried out so the stability of the apatite and the carbonate content after heating/sintering is unknown.
Neutralization of a Ca(M2 solution with H3P04 under stirring at 37'C in presence Of C02 [A. Bigi, F.
Marchetti, A. RiPamonti, N. Roveri and E. Foresti, "Magnesium and strontium interaction with carbonate containing hydroxyapatite in aqueous medium", J.
Inorg. Biochem. 15 (1981) 317-3271. The product is stored for one week in contact with the mother solution, then filtered, washed with distilled water, and dried at 1000C. Hydroxyapatite with a Ca/P molar ratio of 1.95 is obtained. The carbonate content (FTIRI is 6 wt% in a sample dried at 1000C, decreasing to a value of 2.5 wt% in a sample heat treated at 7000C, and is undetectable at 10000C.
EP-A-0722773 and JP-A-8225312 disclose the preparation of an A-type substituted hydroxyapatite in which the carbonate ions substitute for OHions in the structure.
EP-A-0626590 discloses the preparation of a carbonate substituted apatite in which the Ca/P ratio is maintained at approximately 1.66 and sodium and carbonate ions are co-substituted into the lattice with the amount of carbonate that is substituted being controlled by the amount of sodium bicarbonate used in the reaction.
WO-A-94/08458 discloses a process for the preparation of carbonated hydroxyapatite in which the starting materials are mixed at room temperature and the material sets to form a cement at room or physiological temperature. The source of carbonate ions is solid calcium carbonate. The material produced is poorly-crystalline or amorphous apatite which contains sodium ions.
JP-A-61151011 discloses adding Ca(OH)2 and CaCO3 to a slurry of CaHP04. The C03 ions are introduced into the reaction mixture as insoluble CaC03 and not via solution. The ratios of Ca/P used are always less than 1.67. After sintering at 1000' to 11000C the carbonate content of the resulting material is less than 0.1%.
It is mainly due to the problems encountered with the preparation routes discussed above that these routes have not been developed to prepare carbonate substituted hydroxyapatite ceramic materials commercially.
We have now developed a novel process for the preparation of a substantially single phase carbonate substituted hydroxyapatite composition which overcomes the problems of the prior art methods and does not contain sodium or ammonium ions.
Accordingly, the present invention provides a process for the preparation of a carbonate-substituted hydroxyapatite, which process comprises heating an hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 at a temperature of from 600 to 12000C in an atmosphere comprising C02.
Preferably the atmosphere also comprises H20.
The presence of H20 appears to increase the maximum temperature that can be used without decomposition of the product.
Carbonate-substituted hydroxyapatites, containing between 0 and 5 Wt% C03 2-, may be prepared by this simple process. Furthermore, the carbonate substituted hydroxyapatites produced by this process are substantially single phase. This means that greater than 98%, preferably greater than 99% and most preferably approximately 100% of the structure is of a single phase. Also, the carbonate-substituted hydroxyapatites produced by this process are substantially free of sodium and ammonium ions.
Carbonate-substituted hydroxyapatites prepared by this process have both A-type and B-type substitution.
When the heat-treatment takes place at a lower temperature, such as 600-7000C, there is a roughly equal mix of A-type and B-type substitution and the products may be represented by the general formula Calo (P04) 6-x (C03) x (OH) 2-x (C03) x where x is greater than 0 and less than or equal to 0.5.
Commonly however some A-type substituted carbonate is lost on heat treatment at higher temperatures, such as 900- 1000'C or above, and this is most noticeable as the level of carbonate substitution is increased. Higher temperatures such as 900-1000'C are required to sinter the carbonate-substituted hydroxyapatite to near-theoretical densities, for applications such as granules and dense and porous ceramics. The loss of carbonate can be represented by the equation below:
Calc) (P04) 6-x (C03) X (OH) 2-x (C03) x 1 Calo (P04) 6-x (C03) x (OH) 2-X (C03) x-yOy + YC02 Where y increases as the temperature increases. There is a point, when y increases significantly, where CaO will form. Thus, at higher temperatures, carbonatesubstituted hydroxyapatites will (a) eventually decompose to a purely B-type carbonate-substituted hydroxyapatite and calcium oxide and (b) be limited in the amount of carbonate substitution that can be made.
In the context of the present specification hydroxyapatites having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 will be referred to as "Ca-rich" hydroxyapatites.
A Ca-rich hydroxyapatite is preferably prepared by process which comprises as an essential step a precipitation reaction between Ca(OW2 and H3P()4.
A suitable process for preparing a Ca-rich hydroxyapatite, which comprises as an essential step a precipitation reaction between Ca(OH)2 and H3PC)4, may comprise the steps of:
(i) providing a suspension of Ca(OH)2 in water and a solution of H3P04 in water, (ii) adding the solution to the suspension, preferably in a dropwise manner, to provide a mixture wherein the molar ratio of Ca/P is greater than 1.67 but less than approximately 1.82, (iii) optionally adjusting the pH of the mixture resulting from step (ii) to a value in the range of from 10 to 11, preferably by the addition of ammonia, (iv) optionally stirring the mixture resulting from step (ii) or step (iii), preferably for a period of from 1 to 3 hours, (v) allowing the mixture obtained from any one of steps (ii), (iii) or (iv) to age without stirring, preferably for a period of from 5 to 24 hours, (vi) isolating solid material from the mixture resulting from step (v), preferably by filtration, (vii) drying the solid material isolated in step (vi), preferably by heating at approximately 800C for a period of from 5 to 24 hours, (viii) optionally forming the dry solid material resulting from step (vii) into a powder, said powder preferably consisting of particles substantially all of which have a particle size of less than approximately 10Ogm.
For the Ca-rich mixtures resulting from step (ii), i.e. Ca/P > 1.67, the pH will generally be greater than 9, and for Ca/P > 1.70 the pH will be greater than 10, thus ideally no ammonia needs to be added.
By preparing the hydroxyapatite with a Ca/P molar ratio > 1.67 but less than approximately 1.82, vacancies' or IspacesF are left in the phosphate sites of the hydroxyapatite structure. The extent of incorporation Of C03 2- into the structure depends upon the number of available 'vacancies' and can therefore be controlled by controlling the Ca/P molar ratio, i.e. the higher the Ca/P molar ratio, the more carbonate ions can be substituted into the structure.
Preferably the hydroxyapatite is prepared with a Ca/P molar ratio in the range of from 1.69 to 1.82, more preferably from 1.72 to 1.78. Most preferably the Ca/P molar ratio is approximately 1.76.
The calcium-rich hydroxyapatites are heattreated/sintered at a temperature of from 600 to 12000C, depending upon the desired carbonate content and the desired density properties of the product. As mentioned above, lower temperatures result in higher levels of carbonate substitution since carbonate is lost as C02 at higher temperatures. However, at higher temperatures a higher density sintered product is obtained. Thus, the choice of temperature results from a balance between the desired carbonate content and the desired density properties of the product.
Preferably the heating occurs at a temperature of from 850 to 10OCC. More preferably the heating occurs at a temperature of from 900 to 9500C.
Preferably a tube furnace is used for the heating process. The tube furnace is sealed at both ends with one or more gas inlets and one or more gas outlets attached at either end. The rate of heating to the desired temperature may be from 1 to 20'/min, preferably from 2.5 to 5'/min and most preferably approximately 2.50/min.
Above these temperatures, partial decomposition to hydroxyapatite + CaO/CaCO3 is observed. This therefore results in a product which is not substantially single phase. The C02 from the sintering atmosphere is incorporated into the hydroxyapatite structure as C03 2- groups which occupy, predominantly, the phosphate sites.
The concentration of C02 in the atmosphere may be controlled by altering the flow-rate Of C02 gas through the heating apparatus. Preferably the flowrate is in the range of from 0.5 to 3 llmin, more preferably from 1 to 2 1/min and most preferably approximately 1.5 1/min.
The concentration of H20 in the atmosphere, if included, will depend upon the concentration of C02 and the heating temperature. A suitable concentration of H20 in the atmosphere may be achieved by passing the C02 gas through a container of water, preferably at room temperature, prior to its entry into the heating apparatus.
The heating may be carried out for a period of from 1 to 24 hours. Preferably, the heating is carried out for a period of from 1 to 8 hours. More preferably, the heating is carried out for a period of from 1 to 4 hours. Most preferably the heating is carried out for a period of from 1 to 2 hours.
By the method of the present process, a dense, crystalline, single-phase carbonate-substituted hydroxyapatite is obtained. The process allows a controlled amount of carbonate ions to be substituted into hydroxyapatite, with the amount being determined by the level of Ca/P molar ratio i.e. the higher the Ca/P molar ratio, the more carbonate ions can be substituted into the structure. A carbonatesubstituted hydroxyapatite can be prepared by this method which has a carbonate content comparable to bone, with the carbonate substitution being predominantly on the B-site (the phosphate site) of hydroxyapatite. This process is extremely simple and it reduces the possibility of producing a material that will not be single-phase.
The carbonated hydroxyapatite compositions prepared in accordance with the present invention may be used in any of the applications for which hydroxyapatite is used, for example; the formation of plasma-sprayed coatings on metallic implants, the formation of porous ceramic bone substitutes, the preparation of composites with polymeric materials such as high density polyethylene, as granules or beads for packing or filling bone defects, as materials for use in chromatography or as materials for use in purification methods such as the removal of heavy metals by adsorption.
The present invention will be further described with reference to the accompanying drawings in which:
Figure 1 shows an X-ray diffraction pattern for a Ca-rich hydroxyapatite (HA) having Ca/P = 1.76 which has been heat-treated at 900'C in C02/H20. For comparison there is also shown an X-ray diffraction pattern for stoichiometric hydroxyapatite (HA) having Ca/P = 1.67 which has also been heat-treated at 9000C in C02/H20. The standard peaks of HA are marked on the diagram by black dots (from the ICDD (JCPDS) standard for HA, PDF No. 9- 432).
Figure 2 shows an X-ray diffraction pattern for a Ca-rich hydroxyapatite (HA) having Ca/P = 1.76 as precipitated. For comparison there is also shown an X-ray diffraction pattern for stoichiometric hydroxyapatite (HA) having Ca/P = 1.67 as precipitated.
The present invention will be further described by reference to the following examples (and comparative examples) which are intended to illustrate the present invention but not to limit its scope.
Exgm ples Initial vrenaration of stoichiometric and Ca-rich hydroxyapatijes.
A 'calcium' suspension (suspension A) was prepared by dispersing the appropriate quantity, see Table 1, of Ca (OH) 2 (BDH AnalaR) in 1 litre of deionised water. Suspension A was stirred for 15 minutes prior to the precipitation reaction. Phosphoric acid, H3P041 (BDH GPR 85% assay 0.3 moles 34.588g) was added to 1 litre of deionised water (solution B). Solution B was stirred for 15 minutes prior to the precipitation reaction.
Solution B was added dropwise to suspension A, which was stirred constantly; the addition of solution B took approximately 3 hours and was performed at room temperature. After the solution B was added, the pH of the resulting mixture (mixture C) was adjusted to 10.5-11 with ammonia (BDH AnalaR). Mixture C was then stirred for 2 hours and aged overnight without stirring. The aged mixture C was filtered and the resulting filtercake was dried at 800C overnight. The dried filtercake was crushed and ground to a fine powder.
Sample ED Name Ca (moles) CaffiH)2(g) Ca/P CaAP=1.67 Stoichiometric hydroxyapatite 0.500 37.049 1.67 Ca/l---1.72 Ca-rich hydroxyapatite 0.516 38.250 1.72 Ca/P=1.76 Ca-fich hydroxyapatite 0.528 39.124 1.76 CaAP=1.78 Ca-fich hydroxyapatite 0.534 39.568 1.78 Table 1. Quantities of Ca (OH) 2 used to prepare Ca-rich hydroxyapatites (Ca/P = 1.72, 1.76 and 1.78) and stoichiometric hydroxyapatite (Ca/P=1. 67). 25 Comparative Example 1: Preparation of carbonatesubstituted hydroxyapatite from stoichiometric hydroxyapatite.
A stoichiometric hydroxyapatite (Ca/P = 1.67) was prepared by the above method. The stoichiometric hydroxyapatite was heat-treated in a tube furnace at 90CC for 2 hours in a C02/H20 atmosphere. The C02/H20 atmosphere was provided by a flow-rate of 1.5 1/min of C02 through the furnace, the C02 being bubbled through water at room temperature prior to entering the furnace. The as- precipitated and the calcined/sintered powders of the stoichiometric hydroxyapatite (Ca/P = 1.67) have been characterised by CHN analysis, XRF, XRD and FTIR.
Comparative Ex@.mple 2.: Preparation of carbonatesubstituted hvdroxvaiDatite from stoichiometric hvdroxvaDatite.
A stoichiometric hydroxyapatite (Ca/P = 1.67) was prepared by the above method. The stoichiometric hydroxyapatite was heat- treated in a tube furnace at 9000C for 2 hours in air. The as- precipitated and the calcined/sintered powders of the stoichiometric hydroxyapatite (Ca/P = 1.67) have been characterised by CHN analysis and XRF.
Example 1: PreiDaration of carbonate-substituted hvdroxvaDatite from Carich hvdroxvaDatite.
A Ca-rich hydroxyapatite (Ca/P = 1.76) was prepared by the above method. The Ca-rich hydroxyapatite was heat-treated in a tube furnace at 90CC for 2 hours in a C02/H20 atmosphere. The C02/H20 atmosphere was provided by a flow-rate of 1.5 1/min of C02 through the furnace, the C02 being bubbled through water at room temperature prior to entering the furnace. The asprecipitated and the calcined/sintered powders of the Ca-rich hydroxyapatite (Ca/P = 1.76) have been characterised by CHN analysise XRF, XRD and FTIR. Results from analysis indicate that the carbonate-substitution is a combined ABtype substitution, described by the formula:
Cajo (P04) 6-x (C03), (OH) 2-x (C03) x-y Oy Substitution is predominantly B-type due to the higher sintering temperature of 9000C that was used, and the associated loss of some C02 from the A-sites.
CoMparative ExamiDle 3-: Preparation of carbonatesu)2stituted hydroxyapatite from Ca-rich hvdroxvanatite.
A Ca-rich hydroxyapatite (Ca/P = 1.76) was prepared by the above method. The Ca-rich hydroxyapatite was heat-treated in a tube furnace at 90CC for 2 hours in air. The as-precipitated and the calcined/sintered powders of the Ca-rich hydroxyapatite (Ca/P = 1.76) have been characterised by CHN analysis and XRF.
CHN and XRF data are summarised in Table 2.
Within the experimental errors of the XRF method, the calculated and measured values are comparable (experimental errors are shown in brackets). The CHN analysis of both the stoichiometric hydroxyapatite and the Ca-rich hydroxyapatite show that both materials in the as-precipitated stage have appreciable levels of C03. These levels will result from the absorption/adsorption Of C03 2- during precipitation, both from solution and from the atmosphere, especially as the precipitate is at a high pH. For stoichiometric hydroxyapatite, this C03'_ 'S lost during heattreatment/ sintering in C02/H20 and in air.
The C03 2- content of the Ca-rich hydroxyapatite increases upon sintering in C02/H20 to a value of 3.2 wt% but decreases on sintering in air.
Sample id Method Ca/P Ca/P 0 2- 2_ (calculated) (XWF) Wt /OC03 Wto/O C03 (as-pptd) (heat-treated) Ca/P=1.67 C02/H20 1.67 1.68(1) 1.7 < 0.1 Stoichiometric Hydroxyapatite Air 1.67 1.68(1) 1.7 0 Ca/P=1.76 C02/H20 1.76 1.75(1) 2.4 3.2 Ca-rich Hydroxyapatite Air 1.76 1.75(1) 2.4 0.5 Table 2: Results of CHN and XRF analysis of carbonatesubstituted hydroxyapatite.
Figures 1 and 2 show X-ray Diffraction data (25-40' 20) for calcined/ sintered (900(5C C02/H20) and as-precipitated Ca-rich hydroxyapatite(HA), respectively; stoichiometric hydroxyapatite is included for reference. No additional phases were observed in any of the diffraction patterns.
Referring to Figure 1, the X-ray diffraction patterns of calcined/sintered samples with Ca/P=1.67 and 1.76 show only peaks corresponding to hydroxyapatite(JCPDS Card no. 9-432, shown by black dots).
The X-ray diffraction pattern of Ca-rich hydroxyapatite sintered in air at 900'C for 2 hours (not shown) gave peaks corresponding to hydroxyapatite and CaO indicating that the as-precipitated material had decomposed due to the large loss of carbonate.

Claims (16)

  1. Claims A process for the preparation of a carbonatesubstituted
    hydroxyapatite, which process 5 comprises heating an hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1. 82 at a temperature of from 600 to 12000C in a atmosphere comprising C02.
  2. 2. A process as claimed in claim 1 wherein the atmosphere additionally comprises H20.
  3. 3. A process as claimed in claim 1 or claim 2 wherein the hydroxyapatite having a Ca/P molar ratio greater than 1.67 but less than approximately 1.82 is synthesised by a process which comprises a precipitation reaction between Ca (OH) 2 and H3P04
  4. 4. A process as claimed in any one of the preceding claims wherein the Ca/P molar ratio is in the range of from 1.69 to 1.82.
  5. 5. A process as claimed in any one of the preceding claims wherein the Ca/P molar ratio is in the range of from 1.72 to 1.78.
  6. 6. A process as claimed in any one of the preceding claims wherein the Ca/P molar ratio is approximately 1.76.
  7. 7. A process as claimed in any one of the preceding claims wherein the heating occurs at a temperature of from 850 to 10000C.
  8. 8. A process as claimed in any one of the preceding claims wherein the heating occurs at a temperature of from 900 to 95CC.
  9. 9. A process as claimed in any one of the preceding claims wherein the concentration Of C02 in the atmosphere is controlled by providing a flow-rate Of C02 gas through the heating apparatus in the range of from 0.5 to 3 1/min.
  10. 10. A process as claimed in any one of claims 2 to 9 wherein H20 is introduced into the atmosphere by passing the atmosphere comprising C02 through a container of water prior to its entry into the heating apparatus.
  11. 11. A process as claimed in any one of the preceding claims wherein the heating is carried out for a period of from 1 to 24 hours.
  12. 12. A process as claimed in any one of the preceding claims wherein the heating is carried out for a period of from 1 to 2 hours.
  13. 13. A substantially single phase carbonate- substituted hydroxyapatite whenever produced by a process as claimed in any one of claims 1 to 12.
  14. 14. A substantially single phase carbonate substituted hydroxyapatite according to claim 13 2containing between 0 and 5 wt% C03
  15. 15. A substantially single phase carbonatesubstituted hydroxyapatite according to claim 13 35 or claim 14 which is substantially free of sodium and ammonium ions.
  16. 16. A process substantially as hereinbefore described with reference to the example.
GB9910847A 1999-05-10 1999-05-10 Preparing carbonated hydroxyapatite Withdrawn GB2349877A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB9910847A GB2349877A (en) 1999-05-10 1999-05-10 Preparing carbonated hydroxyapatite
AU45921/00A AU4592100A (en) 1999-05-10 2000-05-05 Method for the preparation of carbonated hydroxyapatite compositions
PCT/GB2000/001738 WO2000068144A1 (en) 1999-05-10 2000-05-05 Method for the preparation of carbonated hydroxyapatite compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9910847A GB2349877A (en) 1999-05-10 1999-05-10 Preparing carbonated hydroxyapatite

Publications (2)

Publication Number Publication Date
GB9910847D0 GB9910847D0 (en) 1999-07-07
GB2349877A true GB2349877A (en) 2000-11-15

Family

ID=10853188

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9910847A Withdrawn GB2349877A (en) 1999-05-10 1999-05-10 Preparing carbonated hydroxyapatite

Country Status (3)

Country Link
AU (1) AU4592100A (en)
GB (1) GB2349877A (en)
WO (1) WO2000068144A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2338531A1 (en) * 2009-12-28 2011-06-29 AKADEMIA GORNICZO-HUTNICZA im. Stanislawa Staszica Method for fabrication of synthetic bioceramic implant material based on carbonate hydroxyapatites
EP2632504B1 (en) 2010-10-26 2019-09-04 Cap Biomaterials, LLC Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015086097A (en) * 2013-10-30 2015-05-07 三菱製紙株式会社 (carbonate) calcium apatite containing strontium and method of producing fine particle of the same
PL442461A1 (en) * 2022-10-06 2024-04-08 Sieć Badawcza Łukasiewicz - Instytut Ceramiki I Materiałów Budowlanych Synthetic bioactive hydroxyapatite material and method of its preparation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008458A1 (en) * 1992-10-16 1994-04-28 Norian Corporation Carbonated hydroxyapatite compositions and uses
EP0625490A1 (en) * 1993-05-19 1994-11-23 Queen Mary And Westfield College Method for the preparation of carbonated hydroxyapatite compositions
EP0722772A1 (en) * 1995-01-18 1996-07-24 Mitsubishi Materials Corporation Column packing material comprising OH-carbonated hydroxyapatite
JPH08225312A (en) * 1995-01-18 1996-09-03 Agency Of Ind Science & Technol Production of oh group hydroxyl apatite carbonate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008458A1 (en) * 1992-10-16 1994-04-28 Norian Corporation Carbonated hydroxyapatite compositions and uses
EP0625490A1 (en) * 1993-05-19 1994-11-23 Queen Mary And Westfield College Method for the preparation of carbonated hydroxyapatite compositions
EP0722772A1 (en) * 1995-01-18 1996-07-24 Mitsubishi Materials Corporation Column packing material comprising OH-carbonated hydroxyapatite
JPH08225312A (en) * 1995-01-18 1996-09-03 Agency Of Ind Science & Technol Production of oh group hydroxyl apatite carbonate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WPI abstract 96-450840 & JP 08 225 312 A *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2338531A1 (en) * 2009-12-28 2011-06-29 AKADEMIA GORNICZO-HUTNICZA im. Stanislawa Staszica Method for fabrication of synthetic bioceramic implant material based on carbonate hydroxyapatites
EP2632504B1 (en) 2010-10-26 2019-09-04 Cap Biomaterials, LLC Composites of hydroxyapatite and calcium carbonate and related methods of preparation and use

Also Published As

Publication number Publication date
AU4592100A (en) 2000-11-21
GB9910847D0 (en) 1999-07-07
WO2000068144A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
JP4540225B2 (en) Process for producing magnesium and carbonate substituted hydroxyapatite
JP2010100521A (en) Single-phase carbonate-substituted hydroxyapatite composition
AU2008237711B2 (en) Biomedical materials
Chaair et al. Synthesis of β-tricalcium phosphate
AU2006263624B2 (en) Biomedical materials
KR20140020605A (en) Whitlockite and method for manufacturing the same
Kannan et al. Synthesis and thermal stability of sodium, magnesium co-substituted hydroxyapatites
CN101880033A (en) Method for preparing calcium phosphate for biological ceramics
JPH0369844B2 (en)
JP2004026648A (en) Method for manufacture alpha- and beta-tricalcium phosphate powder
Song et al. In situ synthesis of silicon-substituted biphasic calcium phosphate and their performance in vitro
GB2349877A (en) Preparing carbonated hydroxyapatite
JPS5951485B2 (en) Production method of CaO-P↓2O↓5-based apatite
JP3668530B2 (en) Method for producing tetracalcium phosphate
Salahi et al. Synthesis and thermal behaviour of β tricalcium phosphate precipitated from aqueous solutions
JPS63159207A (en) Production of hydroxyapatite
JPH06122510A (en) Method for producing hexacalcium phosphate
JP2002137914A (en) Silicic acid-containing apatite
Elliott Formation of Fluoridated Hydroxyapatite by Competitive Attack of OH-and F-ions onto. ALPHA.-or. BETA.-Tricalcium Bis (Orthophosphate)
CHAAIR et al. SYNTHESIS Of b TRICALCIUM PHOSPHATE SYNTHÉSE DU PHOSPHATE TRICALCIQUE b
Sakamoto et al. Formation of Fluoridated Hydroxyapatite from Tricalcium Phosphate (TCP) in Organic Media
JP2020007190A (en) Method for producing hydroxyapatite
Jha¹ et al. EFFECT OF SILICON CONTENT ON THE CHEMICAL AND PHASE COMPOSITION OF NOVEL SILICON-SUBSTITUTED HYDROXYAPATITES.
Sun et al. Structural Investigation of Nano Hydroxyapatites Doped with Mg2+ and F− Ions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)